Live feed
Filing
SC 13G
SC 13G0001085146-21-001052·Celldex Therapeutics, Inc.
Schedule 13G ownership disclosure
Celldex Therapeutics, Inc.
Security class unavailable · CUSIP: 15117B103
Event date: 2021-02-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,015,513
- Percent of class
- 5.0939%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-21-001052
- Form type
- SC 13G
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- Feb 25, 2021
- Reporting period
- Feb 22, 2021
- Description
- Schedule 13G beneficial ownership